Central Drugs Laboratory in Kasauli releases vaccine for cervical cancer Ruchika Sharma16 Feb 2023 4:13 PM ISTNew Delhi: Three batches of approximately 80, 000 doses of HPV vaccine have been released by the Central Drugs Laboratory (CDL) in Kasauli,...
SII cervical cancer vaccine to be available in market this month at Rs 2000 for two doses Roshni Dhar10 Feb 2023 6:00 PM ISTThe Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per...
Health Bulletin 10/February/2023 Roshni Dhar10 Feb 2023 4:44 PM ISTHere are the top health stories for the day:NMC gives deadline to FMGE June 2023 candidates applying for eligibility certificateReferring to the...
COVID vaccine: NTAGI holds meeting on Covovax inclusion as heterologous booster for adults on CoWin portal Ruchika Sharma10 Feb 2023 2:54 PM ISTNew Delhi: National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid-19 vaccine Covovax as...
Serum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for two doses: Sources Ruchika Sharma10 Feb 2023 12:15 PM ISTNew Delhi: The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of...
Govt likely to float global tender for HPV vaccine in April; Serum Institute, Merck may participate Ruchika Sharma30 Jan 2023 12:42 PM ISTNew Delhi: The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunisation programme for girls aged 9 to...
China needs good COVID booster vaccine like Covovax, but they haven't given positive response: Serum Institute CEO Adar Poonawalla Ruchika Sharma29 Jan 2023 12:45 PM ISTAs per sources, NTAGI is likely to soon meet regarding the inclusion of COVID vaccine Covovax on the CoWIN portal as heterologous booster dose for...
Cervical cancer vaccine CERVAVAC to be available in small quantity in 2023, increased next year: Adar Poonawalla Ruchika Sharma27 Jan 2023 1:15 PM ISTTalking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.
Serum Institute of India unveils first made-in-India HPV vaccine for cervical cancer Roshni Dhar25 Jan 2023 4:40 PM ISTChief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, has announced the launch of the first made-in-India Human Papillomavirus...
Health Bulletin 25/January/2023 Roshni Dhar25 Jan 2023 4:28 PM ISTHere are the top health stories for the day:Serum Institute of India launches first made-in-India HPV vaccine for cervical cancerChief Executive...
SII unveils first made-in-India HPV vaccine for cervical cancer Ruchika Sharma25 Jan 2023 11:15 AM IST'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private...
Cooperation needed among multilateral organisations to deal with future outbreaks: SII CEO Adar Poonawalla Ruchika Sharma23 Jan 2023 1:15 PM ISTDavos: Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that...
